Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Location
7171 Frederick Banting, Suite 270, Building 2, Saint Laurent, Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 669 % +0.26%
Debt-to-equity 17.1 % -4.64%
Return On Equity -78.3 % -152%
Return On Assets -66.9 % -153%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43M shares +1.21%
Common Stock, Shares, Outstanding 43M shares +1.21%
Entity Public Float 129M USD -66.3%
Common Stock, Value, Issued 490M USD +0.83%
Weighted Average Number of Shares Outstanding, Basic 42.9M shares +1.12%
Weighted Average Number of Shares Outstanding, Diluted 42.9M shares +1.12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 87.4M USD -33.3%
General and Administrative Expense 26.4M USD -21%
Operating Income (Loss) -116M USD -21.1%
Nonoperating Income (Expense) 7.23M USD -40.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -109M USD -30%
Income Tax Expense (Benefit) 1.1M USD -23.9%
Net Income (Loss) Attributable to Parent -110M USD -60.3%
Earnings Per Share, Basic -2 USD/shares -58.9%
Earnings Per Share, Diluted -2 USD/shares -57.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.7M USD -15.2%
Marketable Securities, Current 41.8M USD -67.4%
Assets, Current 127M USD -44.6%
Property, Plant and Equipment, Net 72K USD -97.8%
Operating Lease, Right-of-Use Asset 629K USD -71.3%
Other Assets, Noncurrent 600K USD +95.4%
Assets 130M USD -44.6%
Accounts Payable, Current 4.01M USD -44.1%
Employee-related Liabilities, Current 1.88M USD -57.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 20.1M USD -36.1%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 20.1M USD -36.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8K USD +94%
Retained Earnings (Accumulated Deficit) -465M USD -31%
Stockholders' Equity Attributable to Parent 110M USD -45.8%
Liabilities and Equity 130M USD -44.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.1M USD -344%
Net Cash Provided by (Used in) Financing Activities 79K USD -78.9%
Net Cash Provided by (Used in) Investing Activities 28.8M USD
Common Stock, Shares, Issued 43M shares +1.21%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -262K USD +96.7%
Deferred Tax Assets, Valuation Allowance 140M USD +25.3%
Deferred Tax Assets, Gross 140M USD +25.3%
Operating Lease, Liability 1.93M USD -43.3%
Depreciation 1.19M USD +137%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -110M USD -60.8%
Lessee, Operating Lease, Liability, to be Paid 2M USD -43%
Property, Plant and Equipment, Gross 11.5M USD -0.18%
Operating Lease, Liability, Current 649K USD -66.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88K USD -91.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -23.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +140%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68K USD -33.3%
Deferred Tax Assets, Operating Loss Carryforwards 92.7M USD +32.6%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 590K USD -3.75%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 16.2M USD -37.1%